合理使用骨质疏松症诊疗的骨代谢标志物指南(2004年版)

被引：16

作者：

周丽珍

向青

刘忠厚

机构：

[1] 日本骨质疏松症学会关于合理使用骨质疏松症诊疗的骨代谢标志物指南讨论委员会

[2] 北京中医药大学东方医院

[3] 北京中日友好医院临研所

来源：

中国骨质疏松杂志 | 2004年 / 04期

关键词：

骨代谢; 骨质疏松症; 标志物;

D O I：

暂无

中图分类号：

R58 [内分泌腺疾病及代谢病];

学科分类号：

摘要：

我国骨质疏松医学事业近年来发展很快,但骨质疏松生化标志物的诊断发展滞后,我们看到日本骨质疏松杂志,2004,12(2)发表的"合理使用骨质疏松症诊疗的骨代谢标志物指南"一文很好,现全文译成中文供大家参考,以推动我国骨质疏松生化诊断工作的开展。

引用

页码：15 / 22

页数：8

共 7 条

[1] Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial [J].

Morii, H ;

Ohashi, Y ;

Taketani, Y ;

Fukunaga, M ;

Nakamura, T ;

Itabashi, A ;

Sarkar, S ;

Harper, K .

OSTEOPOROSIS INTERNATIONAL, 2003, 14 (10) :793-800

[2] Diagnostic criteria for primary osteoporosis: year 2000 revision [J].

Orimo, H ;

Hayashi, Y ;

Fukunaga, M ;

Sone, T ;

Fujiwara, S ;

Shiraki, M ;

Kushida, K ;

Miyamoto, S ;

Soen, S ;

Nishimura, J ;

Oh-hashi, Y ;

Hosoi, T ;

Gorai, I ;

Tanaka, H ;

Igai, T ;

Kishimoto, H .

JOURNAL OF BONE AND MINERAL METABOLISM, 2001, 19 (06) :331-337

[3] Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis [J].

Bjarnason, NH ;

Sarkar, S ;

Duong, T ;

Mitlak, B ;

Delmas, PD ;

Christiansen, C .

OSTEOPOROSIS INTERNATIONAL, 2001, 12 (11) :922-930

[4]

The Use of Biochemical Markers of Bone Turnover in Osteoporosis.[J].P. D. Delmas;R. Eastell;P. Garnero;M. J. Seibel;J. Stepan.Osteoporosis International.2000, 6s

[5] Clinical use of biochemical markers of bone remodeling: Current status and future directions [J].

Looker, AC ;

Bauer, DC ;

Chesnut, CH ;

Gundberg, CM ;

Hochberg, MC ;

Klee, G ;

Kleerekoper, M ;

Watts, NB ;

Bell, NH .

OSTEOPOROSIS INTERNATIONAL, 2000, 11 (06) :467-480

[6] Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study [J].

Ross, PD ;

Kress, BC ;

Parson, RE ;

Wasnich, RD ;

Armour, KA ;

Mizrahi, IA .

OSTEOPOROSIS INTERNATIONAL, 2000, 11 (01) :76-82

[7] A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis [J].

Shiraki, M ;

Kushid, K ;

Fukunaga, M ;

Kishimoto, H ;

Taga, M ;

Nakamura, T ;

Kaneda, K ;

Minaguchi, H ;

Inoue, T ;

Morii, H ;

Tomita, A ;

Yamamoto, K ;

Nagata, Y ;

Nakashima, M ;

Orimo, H .

OSTEOPOROSIS INTERNATIONAL, 1999, 10 (03) :183-192

← 1 →